{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T21:07:22Z","timestamp":1770412042663,"version":"3.49.0"},"reference-count":87,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Pharmacoeconomics &amp; Outcomes Research"],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1586\/14737167.2.3.219","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T08:09:27Z","timestamp":1105603767000},"page":"219-228","source":"Crossref","is-referenced-by-count":1,"title":["Cost-effectiveness of alternative strategies to prevent trachomatous blindness"],"prefix":"10.1586","volume":"2","author":[{"given":"Kevin D","family":"Frick","sequence":"first","affiliation":[{"name":"Johns Hopkins Bloomberg School of Public Health, Department of Health Policy and Management, Johns Hopkins University, Department of Economics, Johns Hopkins University, Department of Ophthalmology, 624 N. Broadway, Rm. 606, Baltimore, MD 21205-1901, USA. kfrick@jhsph.edu"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M Arantxa","family":"Colchero","sequence":"additional","affiliation":[{"name":"Johns Hopkins Bloomberg School of Public Health, Department of Health Policy and Management, 624 N. Broadway, Baltimore, MD 21205-1901, USA. arantxacolchero@hotmail.com"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,1,9]]},"reference":[{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","unstructured":"Tabbara KR Trachoma: a review. j Chemother 13\\(Suppl. 1) 18\u201322 (2001).","DOI":"10.1080\/1120009X.2001.11782323"},{"key":"e_1_2_1_6_1","first-page":"477","article-title":"Taylor HR","volume":"65","author":"Thylefors B","year":"1987","unstructured":"Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR. A simplified system for assessment of trachoma and its complications. Bull. World Health Organ. 65,477\u2013483 (1987).","journal-title":"A simplified system for assessment of trachoma and its complications. Bull. World Health Organ"},{"key":"e_1_2_1_7_1","unstructured":"\u2022\u2022Presents a clear description of the differentstates associated with trachoma and its complications."},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","unstructured":"Emerson PM Bailey RL Walraven GE Lindsay SW Human and other faeces as breeding media of the trachoma vector Musca sorbens. Med. Vet. Entomol 15(3) 314\u2013320 (2001).","DOI":"10.1046\/j.0269-283x.2001.00318.x"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","unstructured":"Guraksin A Gullulu G. Prevalence of trachoma in eastern Turkey. Int. J. Epidemiol 26(2) 436\u2013442 (1997).","DOI":"10.1093\/ije\/26.2.436"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1991.01080060119038"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","unstructured":"West S Munoz B Lynch M Kayongoya A Chilangwa Z Mmbaga BB Taylor HR. Impact of face-washing on trachoma in Kongwa Tanzania. Lancet 21 345(8943) 155\u2013158 (1995).","DOI":"10.1016\/S0140-6736(95)90167-1"},{"key":"e_1_2_1_12_1","unstructured":"\u2022\u2022Reports on the effects of a community-based randomized trial of a face-washing intervention after a mass treatment campaign with topical antibiotic."},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","unstructured":"Mabey D Fraser-Hurt N. Trachoma. BE Med 323(7306) 218\u2013221 (2001).","DOI":"10.1136\/bmj.323.7306.218"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","unstructured":"Frick KD Melia BM Buhrmann RR West SK. Trichiasis and disability in a trachoma-endemic area of Tanzania. Arch. Ophthalmol 119(12) 1839\u20131844 (2001).","DOI":"10.1001\/archopht.119.12.1839"},{"key":"e_1_2_1_15_1","unstructured":"\u2022\u2022Documents a statistically significantimpact of trichiasis on functional status even prior to having visual impairment."},{"key":"e_1_2_1_16_1","doi-asserted-by":"crossref","unstructured":"Yeung YM Hon CY Ho CK. A simple surgical treatment for upper lid trichiasis. Ophthalmic Surg. Lasers 28(1) 74\u201376 (1997).","DOI":"10.3928\/1542-8877-19970101-17"},{"issue":"3","key":"e_1_2_1_17_1","first-page":"247","article-title":"Laboratory techniques for diagnosis of chlamydial infections of the eye.j Commun","volume":"29","author":"Baveja UK","year":"1997","unstructured":"Baveja UK, Hiranandani MK, Talwar P, Sen DK. Laboratory techniques for diagnosis of chlamydial infections of the eye.j Commun. Dis. 29(3), 247\u2013253 (1997).","journal-title":"Dis"},{"key":"e_1_2_1_18_1","unstructured":"\u2022Demonstrates the important differences between clinical manifestations of the disease and laboratory tests for chlarnydial infection."},{"issue":"4","key":"e_1_2_1_19_1","first-page":"217","article-title":"Current trends in trachoma in a previously hyperendemic area","volume":"46","author":"The Trachoma Study Group","year":"1998","unstructured":"The Trachoma Study Group. Current trends in trachoma in a previously hyperendemic area. Indianj Ophthalmol 46(4), 217\u2013220 (1998).","journal-title":"Indianj Ophthalmol"},{"key":"e_1_2_1_20_1","doi-asserted-by":"crossref","unstructured":"Zerihun N. Trachoma in Jimma zone south western Ethiopia. Pop. Med. Int. Health 2(12) 1115\u20131121 (1997).","DOI":"10.1046\/j.1365-3156.1997.d01-211.x"},{"key":"e_1_2_1_21_1","doi-asserted-by":"crossref","unstructured":"Congdon N West S Vitale S Katala S Mmbaga BB. Exposure to children and risk of active trachoma in Tanzanian women. Am. Epidemiol 137(3) 366\u2013372 (1993).","DOI":"10.1093\/oxfordjournals.aje.a116683"},{"issue":"12","key":"e_1_2_1_22_1","first-page":"1037","article-title":"Prevalence and risk factors for trachoma in Sarlahi district, Nepal. BE J","volume":"80","author":"Katz J","year":"1996","unstructured":"Katz J, West KP Jr, Khatry SK et al. Prevalence and risk factors for trachoma in Sarlahi district, Nepal. BE J. Ophthalmol 80(12), 1037\u20131041 (1996).","journal-title":"Ophthalmol"},{"key":"e_1_2_1_23_1","doi-asserted-by":"crossref","unstructured":"Hsieh YH Bobo LD Quinn TO West SK. Risk factors for trachoma: 6-year follow-up of children aged 1 and 2 years. Am. J. Epidemiol 152(3) 204\u2013211 (2000).","DOI":"10.1093\/aje\/152.3.204"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1076\/opep.9.2.105.1522"},{"key":"e_1_2_1_25_1","unstructured":"\u2022\u2022Describes a study to enhance knowledgeabout flies as a vector of trachoma transmission."},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a008659"},{"key":"e_1_2_1_27_1","unstructured":"\u2022Key article because in the process of describing risk-factors for constant severe active disease the authors also describe the risk-factors for complications."},{"key":"e_1_2_1_28_1","doi-asserted-by":"crossref","unstructured":"Taylor HR. Trachoma in Australia. Med. J. Aust. 175(7) 371\u2013372 (2001).","DOI":"10.5694\/j.1326-5377.2001.tb143622.x"},{"key":"e_1_2_1_29_1","unstructured":"http:\/\/www.who.intipbditrachomai ebres98-e.htm."},{"issue":"1","key":"e_1_2_1_30_1","first-page":"115","article-title":"Global data on blindness","volume":"73","author":"Thylefors B","year":"1995","unstructured":"Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull. World Health Organ. 73(1),115\u2013121 (1995).","journal-title":"Bull. World Health Organ"},{"key":"e_1_2_1_31_1","unstructured":"\u2022This is a reference for the prevalence rates of blindness generally \u2014 by region and by disease."},{"key":"e_1_2_1_32_1","doi-asserted-by":"crossref","unstructured":"Ranson MK Evans TG. The global burden of trachomatous visual impairment: I. Assessing prevalence. Int. Ophthalmol 19(5) 261\u2013270 (1995\u20131996). First in a set of two papers that set the standard in terms of transparent methods of estimating the global burden of trachoma.","DOI":"10.1007\/BF00130920"},{"key":"e_1_2_1_33_1","doi-asserted-by":"crossref","unstructured":"Evans T Ranson MK. The global burden of trachomatous visual impairment: II. Assessing burden. Int. Ophthalmol 19(5) 271\u2013280 (1995\u20131996).","DOI":"10.1007\/BF00130921"},{"key":"e_1_2_1_34_1","unstructured":"\u2022Second in a set of two papers that set the standard in terms of transparent methods of estimating the global burden of trachoma except that the pharmacoeconomic outcome measure is not a standard measure."},{"key":"e_1_2_1_35_1","first-page":"1","article-title":"Geneva, Switzerland, World Health Organization","volume":"97","author":"Report of the First Meeting of the WHO Alliance for the Global Elimination of Trachoma","year":"1997","unstructured":"Report of the First Meeting of the WHO Alliance for the Global Elimination of Trachoma. Geneva, Switzerland, World Health Organization. (unpublished document WHO\/PBUGET\/97.1) (1997).","journal-title":"unpublished document WHO\/PBUGET\/"},{"key":"e_1_2_1_36_1","unstructured":"\u2022Gives a flavor of the Alliance for the Global Elimination of Trachoma meetings. Three reports are online at present."},{"key":"e_1_2_1_37_1","doi-asserted-by":"crossref","unstructured":"Dawson CR Schachter J Sallam S Sheta A Rubinstein RA Washton H. A comparison of oral azithromycin with topical oxytetracyclineipolymyxin for the treatment of trachoma in children. Gun. Infect. Dis. 24(3) 363\u2013368 (1997).","DOI":"10.1093\/clinids\/24.3.363"},{"key":"e_1_2_1_38_1","unstructured":"Fraser-Hurt N Bailey RL Cousens S Mabey D Faal H Mabey DC. Efficacy of oral azithromycin versustopical tetracycline in mass treatment of endemic trachoma. Bull. World Health Organ. 79(7) 632\u2013640 (2001)."},{"key":"e_1_2_1_39_1","unstructured":"\u2022One of several recent studies on the efficacy or effectiveness of azithromycin that usefully supplement the limited cost-effectiveness studies."},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)12387-5"},{"key":"e_1_2_1_41_1","unstructured":"\u2022\u2022Documents the similar efficacy ofazithromycin and tetracycline in multiple settings."},{"key":"e_1_2_1_42_1","doi-asserted-by":"crossref","unstructured":"Tabbara KF Abu El Asnar Al Omar 0 Chloudhury AH Al Faisal Z. Single dose azithromycin in the treatment of trachoma a randomized controlled study. Ophthalmology 103 842\u2013846 (1996).","DOI":"10.1016\/S0161-6420(96)30605-2"},{"issue":"3","key":"e_1_2_1_43_1","first-page":"194","article-title":"Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal","volume":"79","author":"Osaki Holm S","year":"2001","unstructured":"Osaki Holm S et al. Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal. Bull. World Health Organ. 79(3), 194\u2013200 (2001).","journal-title":"Bull. World Health Organ"},{"key":"e_1_2_1_44_1","doi-asserted-by":"crossref","unstructured":"Leach AJ Shelby-James TM Mayo M et al. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin. Infect. Dis. 24(3) 356\u2013362 (1997).","DOI":"10.1093\/clinids\/24.3.356"},{"key":"e_1_2_1_45_1","unstructured":"\u2022This study among all concerned with the use of azithromycin in mass treatment against trachoma most strongly suggests a relationship to resistant strains of bacteria."},{"key":"e_1_2_1_46_1","unstructured":"Treadway G. Azithromycin: a new 15- membered macrolide. Jpn I Antibiot 54(Suppl A) 70\u201376 (2001)."},{"key":"e_1_2_1_47_1","doi-asserted-by":"crossref","unstructured":"Duran JM Amsden GW. Azithromycin: indications for the future? Expert Opin. Pharmacother. 1(3) 489\u2013505 (2000).","DOI":"10.1517\/14656566.1.3.489"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.83.12.1332"},{"key":"e_1_2_1_49_1","unstructured":"\u2022Concludes that the clinical relevance of the effects of mass treatment against trachoma on other bacterial flora has yet to be determined."},{"key":"e_1_2_1_50_1","doi-asserted-by":"crossref","unstructured":"Peterson J Treadway G. Impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin. Infect. Dis. 26(1) 248\u2013249 (1998).","DOI":"10.1086\/517046"},{"key":"e_1_2_1_51_1","unstructured":"\u2022This letter should be read in combination with the Leach et al. [29]."},{"key":"e_1_2_1_52_1","unstructured":"Bowman RJ Sillah A Van Dehn C et al Operational comparison of single-dose azithromycin and topical tetracycline for trachoma. Invest. Ophthalmol Vis. Sc]. 41(13) 4074\u20134079 (2000)."},{"key":"e_1_2_1_53_1","unstructured":"\u2022\u2022Compared azithromycin and tetracyclinein a less rigorously administered setting that attempted to measure effectiveness rather than efficacy Performed a simple cost-effectiveness comparison of using azithromycin generally with using it for only cases of infection with more severe clinical symptoms."},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-5155(00)00284-7"},{"key":"e_1_2_1_55_1","doi-asserted-by":"crossref","unstructured":"Oguz H Aras C Ozdamar A. Thermoablation treatment for trichiasis in trachoma using the semiconductor diode pumped laser. Eur. j Ophthalmol 9(2) 85\u201388 (1999).","DOI":"10.1177\/112067219900900202"},{"issue":"5","key":"e_1_2_1_56_1","first-page":"468","article-title":"Bilamellar tarsal rotation is the preferred treatment for trachomatous trichiasis","volume":"43","author":"West S","year":"1999","unstructured":"West S, Taylor HR. Bilamellar tarsal rotation is the preferred treatment for trachomatous trichiasis. Surv. Ophthalmol 43(5), 468 (1999).","journal-title":"Surv. Ophthalmol"},{"key":"e_1_2_1_57_1","doi-asserted-by":"crossref","unstructured":"Graz B Xu JM Yao ZS Han SR Kok A. Trachoma: can trichiasis be treated with a sticking-plaster? A randomized clinical trial in China. Tmp. Med. Int. Health 4(3) 222\u2013228 (1999).","DOI":"10.1046\/j.1365-3156.1999.43375.x"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1076\/opep.8.2.155.4165"},{"key":"e_1_2_1_59_1","unstructured":"\u2022Documents the recurrence rate and severe recurrence rate of trichiasis after surgery over the longest time period to date."},{"issue":"2","key":"e_1_2_1_60_1","first-page":"258","article-title":"SR Preventing trachoma through environmental sanitation: a review of the evidence base","volume":"78","author":"Pruss A","year":"2000","unstructured":"Pruss A, Mariotti SR Preventing trachoma through environmental sanitation: a review of the evidence base. Bull. World Health Organ. 78(2), 258\u2013266 (2000).","journal-title":"Bull. World Health Organ"},{"key":"e_1_2_1_61_1","unstructured":"\u2022Thoroughly reviews the environmental component of the SAFE strategy."},{"key":"e_1_2_1_62_1","unstructured":"Bailey R Lietman T The SAFE strategy for the elimination of trachoma by 2020: will it work? Bull. World Health Organ. 79(3) 233\u2013236 (2001)."},{"key":"e_1_2_1_63_1","doi-asserted-by":"crossref","unstructured":"Evans TG Ranson MK Kyaw TA Ko CK. Cost effectiveness and cost utility of preventing trachomatous visual impairment: lessons from 30 years of trachoma control in Burma. BE J. Ophthalmol 80(10) 880\u2013889 (1996).","DOI":"10.1136\/bjo.80.10.880"},{"key":"e_1_2_1_64_1","unstructured":"\u2022\u2022The only long-term cost-effectivenessstudy in this area."},{"issue":"3","key":"e_1_2_1_65_1","first-page":"201","article-title":"Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children","volume":"79","author":"Frick KD","year":"2001","unstructured":"Frick KD, Lietman TM, Holm SO, Jha HC, Chaudhary JS, Bhatta RC. Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children. Bull. World Health Organ. 79(3), 201\u2013207 (2001).","journal-title":"Bull. World Health Organ"},{"key":"e_1_2_1_66_1","unstructured":"\u2022\u2022The only published cost-effectivenesscomparison of targeted and mass treatment of trachoma."},{"key":"e_1_2_1_67_1","doi-asserted-by":"crossref","unstructured":"Bowman RJ Soma OS Alexander N et al. Should trichiasis surgery be offered in the village? A community randomised trial of village vs. health centre-based surgery. 7i-op. Med. Int. Health 5 (8) 528\u2013533 (2000).","DOI":"10.1046\/j.1365-3156.2000.00605.x"},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1076\/opep.8.2.191.4163"},{"key":"e_1_2_1_69_1","unstructured":"\u2022\u2022The only study to date projecting theeconomic value of the productivity effect of using trichiasis surgery to avert blindness."},{"issue":"2","key":"e_1_2_1_70_1","first-page":"113","article-title":"Azithromycin for the treatment and control of trachoma. Expert Opin","volume":"3","author":"Burton MJ","year":"2002","unstructured":"Burton MJ, Frick KD, Bailey RL, Bowman RJC. Azithromycin for the treatment and control of trachoma. Expert Opin. Pharmacother. 3(2), 113\u2013120 (2002).","journal-title":"Pharmacother"},{"key":"e_1_2_1_71_1","unstructured":"\u2022Contains one supplemental cost-effectiveness analysis to the earlier results presented by Bowman et al. [34] on the cost-effectiveness of giving azithromycin only to those with more severe active disease."},{"issue":"2","key":"e_1_2_1_72_1","first-page":"150","article-title":"[Strategies to control trachoma]","volume":"8","author":"Schemann JP","year":"1998","unstructured":"Schemann JP, Sacko D. [Strategies to control trachoma]. Sante 8(2), 150\u2013156 (1998).","journal-title":"Sante"},{"key":"e_1_2_1_73_1","unstructured":"\u2022\u2022The only cost of trachomatous blindnessavoidance study from Mali."},{"key":"e_1_2_1_74_1","doi-asserted-by":"publisher","DOI":"10.1076\/opep.8.4.205.1607"},{"key":"e_1_2_1_75_1","unstructured":"\u2022Lays out a framework for future cost-effectiveness work in this area."},{"key":"e_1_2_1_76_1","doi-asserted-by":"crossref","unstructured":"Philipson T Dow WH. Infectious disease transmission and infection-dependent matching. Math Biosci. 148 (2) 161\u2013180 (1998).","DOI":"10.1016\/S0025-5564(97)10005-0"},{"key":"e_1_2_1_77_1","doi-asserted-by":"crossref","unstructured":"Lietman T Porco T Dawson C Blower S. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nat. Med. 5(5) 572\u2013576 (1999).","DOI":"10.1038\/8451"},{"key":"e_1_2_1_78_1","unstructured":"\u2022One of the more sophisticated mathematical models of trachoma reinfection to date and suggests the frequency of azithromycin mass treatment administration necessary to eliminate active disease."},{"key":"e_1_2_1_79_1","first-page":"2","article-title":"Geneva, Switzerland, World Health Organization","volume":"98","author":"Report of the Second Meeting of the WHO Alliance for the Global Elimination of Trachoma","year":"1998","unstructured":"Report of the Second Meeting of the WHO Alliance for the Global Elimination of Trachoma. Geneva, Switzerland, World Health Organization. (unpublished document WHO\/PBUGET\/98.2) (1998).","journal-title":"unpublished document WHO\/PBUGET\/"},{"issue":"1","key":"e_1_2_1_80_1","first-page":"8","article-title":"Pilot study of the use of community volunteers to distribute azithromycin for trachoma control in Ghana","volume":"79","author":"Solomon AW","year":"2001","unstructured":"Solomon AW, Akudibillah J, Abugri P et al Pilot study of the use of community volunteers to distribute azithromycin for trachoma control in Ghana. Bull. World Health Organ. 79(1), 8\u201314 (2001).","journal-title":"Bull. World Health Organ"},{"key":"e_1_2_1_81_1","unstructured":"\u2022One of several recent studies of ways to distribute azithromycin for trachoma control."},{"key":"e_1_2_1_82_1","doi-asserted-by":"crossref","unstructured":"Mabey D Fraser-Hurt N. Antibiotics for trachoma (Cochrane Review). Cochrane Database Syst. Rev (1) CD001860 (2002).","DOI":"10.1002\/14651858.CD001860"},{"key":"e_1_2_1_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-5155(00)00167-2"},{"key":"e_1_2_1_84_1","unstructured":"\u2022One of several recent effectiveness studies that are useful as a supplement to the limited cost-effectiveness studies."},{"key":"e_1_2_1_85_1","doi-asserted-by":"crossref","unstructured":"Laming AC Currie BJ DiFrancesco M Taylor HR Mathews JD. A targeted single-dose azithromycin strategy for trachoma. Med. J. Aust. 172 (4) 163\u2013166 (2000).","DOI":"10.5694\/j.1326-5377.2000.tb125541.x"},{"key":"e_1_2_1_86_1","unstructured":"\u2022One of several recent effectiveness studies that are useful as a supplement to the limited cost-effectiveness studies."},{"key":"e_1_2_1_87_1","doi-asserted-by":"crossref","unstructured":"Whitty CJ Glasgow KW Sadiq ST Mabey DC Bailey R. Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children. Fenian: Infect. Dis. 18(11) 955\u20138 (1999).","DOI":"10.1097\/00006454-199911000-00003"},{"key":"e_1_2_1_88_1","unstructured":"\u2022One of several recent effectiveness studies that are useful as a supplement to the limited cost-effectiveness studies."},{"key":"e_1_2_2_2_1","unstructured":"Alliance for the Global Elimination of blinding Trachoma. Description of the disease map prevalence results of specific interventions in some countries objectives of the Global Alliance of Trachoma Control www.who.int\/pbd\/trachoma\/ss\/whoget\/ sld001.htm"},{"key":"e_1_2_2_3_1","unstructured":"International Trachoma Initiative www.trachoma.org\/"},{"key":"e_1_2_2_4_1","unstructured":"Alliance for the Global Elimination of blinding Trachoma reports resolutions simplified trachoma grading including images (Program of the Prevention of Blindness) countries www.who.intipbd\/ trachoma\/pressrel.htm"}],"container-title":["Expert Review of Pharmacoeconomics &amp; Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14737167.2.3.219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T10:15:15Z","timestamp":1770372915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14737167.2.3.219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["10.1586\/14737167.2.3.219"],"URL":"https:\/\/doi.org\/10.1586\/14737167.2.3.219","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}